PBA
AMAM

Paradigm Biocapital Advisors’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Paradigm Biocapital Advisors’s Portfolio AMAM Stock Details AMAM Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,352,689
Closed -$62M – 38
2023
Q4 		$62M Buy
4,352,689
+864,093
+25% +$12.3M 2.9% 15
2023
Q3 		$40.1M Buy
3,488,596
+1,838,097
+111% +$21.1M 2.72% 16
2023
Q2 		$27.2M Buy
+1,650,499
New +$27.2M 2.1% 17